GrantExec

Grants for Public housing authorities - Health

Explore 2,071 grant opportunities

NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 21, 2025

Date Added

Feb 13, 2025

This grant provides financial support and resources to early-career faculty from underrepresented backgrounds in neuroscience, helping them establish independent research careers through mentorship and protected research time.

Health
State governments
Short Courses in Social Determinants of Health for Research Education in Nursing Research (R25 Independent Clinical Trial Not Allowed)
$250,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jul 1, 2024

Date Added

Nov 1, 2023

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: (1) Courses for Skills Development; and (2) Develop and implement a program to prepare nurse scientists, and scientists in aligned fields, to conduct research on the social determinants of health in alignment with the NINR Strategic Plan.

Education
State governments
Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R01-Clinical Trial Not Allowed)
$499,999
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

May 7, 2024

Date Added

Oct 25, 2023

The purpose of this NIDCD initiative is to encourage research in the development, characterization, and reproducibility/reliability of human auditory and vestibular organoids.Applications investigating animal organoids are allowable but only if accompanying comparative or other integrated companion studies with human organoids. Singular animal organoid studies alone are not responsive to this funding opportunity. This funding opportunity encourages innovative, reproducible, and novel methodologies and technologies that will drive the reproducibility and holistic longevity of hearing/balance sensory organoids as model systems. The development of novel tools to deliver genes, proteins, molecules, and synthetics that might lead to the successful expansion and longer-term survivability of organoid populations in a stable, reliable, and reproducible manner is highly encouraged. Subsequent characterization of the organoid platforms must be shown to mimic and recapitulate the native correlative biological function. Applications that provide approaches that remove current barriers and lessen challenges to improve current reproducibility and stability are highly encouraged. Applications that have breakthrough approaches and technologies using human auditory/vestibular organoids are highly encouraged.

Health
State governments
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Aug 11, 2023

Date Added

Apr 12, 2023

This funding opportunity supports research aimed at understanding how beliefs about cancer treatment outcomes influence symptom management, particularly focusing on underrepresented populations in biomedical research.

Education
State governments
New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)
$200,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

May 7, 2024

Date Added

Mar 8, 2021

This Funding Opportunity Announcement (FOA) seeks innovative grant applications in nonmalignant hematology research that will steer the field in new directions. Applications to this FOA should propose proof of principle research that is tightly focused into one specific aim, which can be accomplished within a 1-3 year project period, and is directed at validating novel concepts and approaches that promise to open new pathways for discovery.The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Aging (NIA) have joined together to build research activities in nonmalignant hematology. This Funding Opportunity Announcement (FOA) is intended to promote innovative research projects in nonmalignant hematology that explore high impact and new directions of inquiry. While each Institute shares interests in nonmalignant hematology research, they also bring different perspectives, thereby expanding the scope of the SHINE II program beyond a single Institute's research mission. This "New Directions in Hematology Research (SHINE-II)" program invites investigator-initiated grant applications for basic or early translational, proof of principle research projects that are tightly focused and directed at validating novel concepts and approaches that promise to advance new pathways for discovery. This program may include clinical research involving human subjects that is directed at understanding disease pathogenesis and prognosis. Research applications submitted under this FOA should be more limited in scope (single aim with sub-aims, as appropriate) and duration (1-3 years) than typical R01 grant applications. The SHINE-II FOA seeks specifically to promote and support new directions of research in their early stages. Applications submitted to this FOA should include preliminary data that support the conceptual basis of the research proposed and the technical approaches to be used. Moreover, while research applications submitted under this FOA are expected to be more limited in scope and shorter in duration than typical R01 applications, achievement of the research objective(s) proposed should validate novel pathways of discovery and provide the basis for future high impact research endeavors. Principal areas of interest for this collaborative FOA include: (1) hematopoietic stem cell biology, (2) lineage fate determinants, (3) aging-related immune dysfunction and lymphocyte biology, (4) myeloid cell biology, and myelopoiesis, (5) platelet biology and dysfunction, (6) erythroid cell biology and erythropoiesis, (7) the molecular biology of heme and hemoglobin, (8) acquired and congenital disorders of red blood cell production and survival leading to chronic anemia or bone marrow failure, (9) and the uptake, utilization, storage, and transport of iron in health and disease. Inquiries to Scientific/Research staff prior to submission of an application to this FOA are strongly encouraged to discuss programmatic relevance and potential time tables for funding (see below, Section VII. Agency Contacts). The limited scope and shorter duration of the SHINE II R01 are not optimal for Early Stage Investigators (ESIs) and New Investigators (NIs), who should contact Scientific/Research staff prior to submission of an application to this FOA.

Food and Nutrition
State governments
Guinea Local Health System Strengthening (GLHSS)
Contact for amount
U.S. Agency for International Development
Federal

Application Deadline

Feb 25, 2025

Date Added

Feb 16, 2022

This grant provides funding to a wide range of organizations, including NGOs and private sector entities, to strengthen local health systems in Guinea, focusing on improving healthcare quality and accessibility in targeted regions.

Health
Public and State controlled institutions of higher education
Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 21, 2025

Date Added

Feb 12, 2025

This funding opportunity supports U.S. higher education institutions in developing research training programs that enhance diversity and prepare underrepresented students for careers in biomedical research.

Health
State governments
NINDS Program Project Grant (P01 Clinical Trial Optional)
Contact for amount
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

May 7, 2024

Date Added

Apr 5, 2021

This funding opportunity announcement (FOA) is issued by the National Institute of Neurological Disorders and Stroke to enable submission of program project grant applications that propose to conduct innovative, interactive research to answer significant scientific questions that are important for the mission of NINDS, via a synergistic collaboration between outstanding scientists who might not otherwise collaborate. The program project grant is designed to support research in which the funding of several interdependent highly meritorious projects as a group offers significant scientific advantages over support of these same projects as individual research grants.

Health
State governments
Population Genomic Screening in Primary Care Cooperative Agreement (U01 - Clinical Trial Required)
$560,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 2, 2024

Date Added

Aug 16, 2024

This funding opportunity supports clinical groups in the U.S. to implement population-based genomic screening in primary care, focusing on identifying and managing common genetic conditions, particularly in underserved communities.

Health
State governments
Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)
$200,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Sep 9, 2025

Date Added

Jan 10, 2023

This funding opportunity supports innovative research projects that aim to improve HIV prevention and care strategies, targeting a wide range of organizations and individuals involved in health and social sciences.

Health
State governments
Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries (LMICs) for Aging and Alzheimers Disease (AD) and AD-Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed)
$100,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 14, 2025

Date Added

Sep 9, 2024

This funding opportunity supports early-career researchers in low- and middle-income countries who are studying aging and dementia, providing them with resources to develop pilot projects and advance their research careers.

Health
State governments
Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)
$10,000,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 17, 2025

Date Added

Dec 17, 2024

This funding opportunity supports research projects that develop and evaluate strategies to improve the transition of care for childhood and adolescent cancer survivors as they move from pediatric to adult healthcare systems.

Education
State governments
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)
$2,000,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Jun 9, 2025

Date Added

May 26, 2022

This funding opportunity supports interdisciplinary research teams focused on understanding the brain mechanisms behind mental disorders and translating these findings into clinical applications, particularly for severe mental illnesses and developmental psychopathology in children and adolescents.

Health
State governments
Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)
$500,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 10, 2024

Date Added

Aug 9, 2024

This Notice of Funding Opportunity (NOFO) seeks to support multidisciplinary research teams with complementary expertise in HIV and pathobiology, pathophysiology, and/or metabolism in organs, tissues, and/or biological systems of specific interest to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). These teams will comprehensively interrogate fundamental biological mechanisms underlying HIV-associated comorbidities, co-infections, and complications relevant to the mission of the NIDDK and advance progress toward preventing or alleviating them.

Food and Nutrition
State governments
Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
$275,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 19, 2024

Date Added

Oct 20, 2023

This funding opportunity provides financial support for research aimed at improving resources and practices for caregivers and professionals who assist children with delayed language development, particularly focusing on underrepresented communities.

Health
State governments
Exploratory/Developmental Research for World Trade Center Health Program Evidence-based Strategies to Improve Treatment Effectiveness, Diagnostic Practices, and Program Evaluation (R21)
$365,000
U.S. Department of Health and Human Services (Centers for Disease Control and Prevention - ERA)
Federal

Application Deadline

Oct 29, 2024

Date Added

Mar 7, 2024

This grant provides funding for innovative research projects aimed at improving the diagnosis and treatment of health conditions related to the September 11 attacks, specifically targeting first responders and survivors affected by these events.

Health
State governments
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 7, 2024

Date Added

Mar 7, 2024

The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.

Education
State governments
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)
$100,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

May 7, 2024

Date Added

May 12, 2020

The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH program that provides support and "protected time" to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research.

Education
State governments
Strengthening Indias integrated HIV/STI tiered laboratory network through continuous quality improvement, surveillance, and laboratory data management under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
$1,000,000
U.S. Department of Health & Human Services (Centers for Disease Control-GHC)
Federal

Application Deadline

Feb 25, 2025

Date Added

Jul 18, 2024

This grant provides funding to organizations in India to improve the quality and accessibility of HIV and STI testing services through enhanced laboratory networks and continuous quality improvement initiatives.

Health
State governments
NIMH Instrumentation Program (S10 Clinical Trial Not Allowed)
$600,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 9, 2024

Date Added

Jan 24, 2022

The NIMH Instrumentation Program grant aims to fund the acquisition of specific research instruments, such as microscopes and biomedical imagers, for mental health-related research, with a focus on data collection rather than instrument development, and encourages housing these instruments in shared facilities for broader use.

Health
State governments